Increased expression of ARL4C protein in GSLCs relative to NSTCs was then confirmed (Fig. 1D) and co-localized with the GSLC marker CD133 in human GBM tissues (Fig. 1E). The gene discussed is ARL4C; the disease is glioblastoma.